Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.

CorEvitas_GPP-510

Study Phase: Registry

Condition(s): Generalized Pustular Psoriasis
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry.

ClinicalTrials.gov NCT ID: NCT06100991

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
Crystal Burke, RN

Crystal Burke, RN

Primary Contact - Study Coordinator

484-658-1489
crystal.burke@sluhn.org

Andrew C. Krakowski, MD

Andrew C. Krakowski, MD

Physician - Principal Investigator

Shanghai Fudan - ZhangJiang Bio-Pharmaceutical Co., Ltd - F0026-US201

Study Phase: Phase II - Drug

Condition(s): Port Wine Birthmark
A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Sequential Group Comparison Study to Evaluate the Safety and Efficacy of Light Dose (Fluence) in Subjects with Port-wine Birthmark Treated with Hemoporfin + Green Light Photodynamic Therapy.

ClinicalTrials.gov NCT ID: NCT05171894

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_monica-hosler

Monica Hosler

Primary Contact - Study Coordinator

484-658-4567
monica.hosler@sluhn.org

Andrew C. Krakowski, MD

Andrew C. Krakowski, MD

Physician - Principal Investigator

To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.

Cancer Ribbon

Transforming lives through philanthropy

Supporting clinical trials and research can help us create a future where advanced health care is accessible and equitable for everyone. Together, we can transform lives and improve health care for generations to come.

Donate today